WRIGHT MEDICAL TECHNOLOGY INC
15-15D, 1998-10-30
ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES
Previous: MORGAN GRENFELL INVESTMENT TRUST, 497, 1998-10-30
Next: GIBRALTAR STEEL CORP, 10-Q, 1998-10-30



FORM  15.--Certification and Notice of Termination of Registration Under Section
12(g)  of the  Securities  Exchange  Act of 1934 or  Suspension  of duty to file
reports under Sections 13 and 15(d) of the Securities Exchange Act of 1934.

                   Commission File Number            33-69286


                         WRIGHT MEDICAL TECHNOLOGY, INC.
     ------------------------------------------------------------------------
             (Exact name of registrant as specified in its charter)

      5677 Airline Road,  Arlington,  Tennessee  38002-0100  (901)867-9971
     ------------------------------------------------------------------------
     (Address, including zip code, and telephone number, including area code,
       of registrant's principal executive offices)


                     11 3/4% Series D Secured Step-Up  Notes 
     ------------------------------------------------------------------------
             (Title of each class of securities covered by this Form)


     ------------------------------------------------------------------------
     (Titles of all other classes of securities for which a duty to file
       reports under section 13(a) or 15(d) remains)

     Please  place  an X in  the  box(es)  to  designate  the  appropriate  rule
provision(s) relied upon to terminate or suspend the duty to file reports:

Rule 12g-4(a)(l)(i)  ---  Rule 12h-3(b)(1)(i) ---  Rule 12g-4(a)(l)(ii) ---
Rule 12h-3(b)(l)(ii) ---  Rule 12g-4(a)(2)(i) ---  Rule 12h-3(b)(2)(i)  ---
Rule 12g-4(a)(2)(ii) ---  Rule 12h-3(b)(2)(ii)---  Rule 15d-6 |X|

Approximate number of holders of record as of the certification notice date: 5

     Pursuant to the requirements of the Securities  Exchange Act of 1934 Wright
Medical Technology,  Inc. has caused this  certification/notice  to be signed on
its behalf by the undersigned duly authorized person.

Date:  October 29, 1998             By:   /s/Greg Butler
                                          Greg Butler
                                          Executive Vice President
                                          Chief Financial Officer

        INSTRUCTION:  This form is required by Rules  12g-4,  12h-3 and 15d-6 of
the General Rules and Regulations under the Securities Exchange Act of 1934. The
registrant  shall file with the Commission three copies of Form 15, one of which
shall be manually signed.  It may be signed by an officer of the registrant,  by
counsel or by any other duly authorized person. The name and title of the person
signing the form shall be typed or printed under the signature.



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission